Anti-Dll4 Monoclonal Antibody REGN421
Cancer Terms ->
Drugs and Chemicals ->
Pharmacologic Substance ->
Biological Agent ->
Monoclonal Antibody -> Anti-Dll4 Monoclonal Antibody REGN421
Anti-Dll4 Monoclonal Antibody REGN421 Definition
A human monoclonal antibody directed against Delta-like ligand-4 (DLL4) with potential antineoplastic activity. Anti-DLL4 monoclonal antibody REGN421 specifically binds to human DLL4, preventing its binding to Notch receptors and inhibiting Notch signaling, which may result in defective tumor vascularization and, so, the inhibition of tumor cell growth. DLL4 is the only Notch ligand selectively expressed on endothelial cells; DLL4/Notch signaling is required for the development of functional tumor blood vessels.
Anti-Dll4 Monoclonal Antibody REGN421 Synonyms
Anti-Dll4 Monoclonal Antibody REGN421, Anti-Delta-Like 4 Monoclonal Antibody REGN421, REGN421
Terms in Anti-Dll4 Monoclonal Antibody REGN421 category
Copyright © Cancer Terms 2014 All rights reserved. | Terms of Use | Low Carb Foods
No reproduction or republication permitted.